Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 9:46 PM
Ignite Modification Date: 2025-12-25 @ 7:25 PM
NCT ID: NCT00295932
Term: Hemorrhage/Bleeding assoc w/surg, intra/ post-op
Organ System: Injury, poisoning and procedural complications
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: None
Notes: None
Study: NCT00295932
Study Brief: Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG001 None 0 6 View
EG002 None 0 3 View
EG004 None 0 2 View
EG006 None 0 3 View
EG008 None 0 10 View
EG000 None 0 4 View
EG003 None 0 4 View
EG005 None 0 18 View
EG007 None 0 4 View
EG009 None 0 12 View
EG010 None 1 13 View